BeiGeneius - Relapsed/refractory Waldenström’s macroglobulinemia: Key considerations for managing pre-treated patients

 VIDEO   01:25:28   03/2021

Relapsed/refractory Waldenström’s macroglobulinemia: Key considerations for managing pre-treated patients

Wednesday, March 10, 2021 | 17:00–18:30 (CET)

 

Professor Christian Buske

University Hospital of Ulm, Germany

 

Ramón García-Sanz

University Hospital of Salamanca, Spain

 

Véronique Leblond

Pitié-Salpêtrière Hospital, France

 

Dr. Alessandra Tedeschi

Niguarda Cancer Center, Italy

Rating

Rate this publication